ACTRIMS Action Center
Explore the forefront of multiple sclerosis research with the ACTRIMS Action Center. Here you’ll find leading experts in the field share insights on the latest studies, innovative treatment approaches, and evolving patient management strategies that emerged from the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum.
Engineering Autoimmunity: A New Model for Studying MS Progression and Remyelination
NeuroFrontiersEngineering Autoimmunity: A New Model for Studying MS Progression and Remyelination
Safety Outcomes in MS Clinical Trials: Examining Comorbidities and Adverse Events
NeuroFrontiersSafety Outcomes in MS Clinical Trials: Examining Comorbidities and Adverse Events
MS and the Ketogenic Diet: Potential Impacts on Inflammation and Relapse
NeuroFrontiersMS and the Ketogenic Diet: Potential Impacts on Inflammation and Relapse
Understanding Prodromal Phases in Demyelinating Diseases: Insights on MS, NMOSD, and MOGAD
NeuroFrontiersUnderstanding Prodromal Phases in Demyelinating Diseases: Insights on MS, NMOSD, and MOGAD
Emerging Technologies in MS: Neuromodulation and Myelin Regeneration
NeuroFrontiersEmerging Technologies in MS: Neuromodulation and Myelin Regeneration
MS and Structural Disconnectivity: Pathophysiology and Emerging Technologies
NeuroFrontiersMS and Structural Disconnectivity: Pathophysiology and Emerging Technologies
